Genprex Inc. - GNPX Company Long-Term Liabilities

Genprex Inc. - graphic logo of issuer GNPX

Genprex, Inc. (GNPX) is minimally exposed to economic fluctuations, as it relies on the constant demand for advanced medicine and clinical trial results. Genprex, Inc. (GNPX) leads the way in developing gene therapy, utilizing AI-nanoparticles for drug delivery into tumors. This daily price chart illustrates the price action of Genprex, Inc. (GNPX), whose future pricing power depends on the outcome of trials, with the metric standing at 0.00.

GNPX (genprex.com) Company Long-Term Debt history from 07/04/2022 to 10/29/2026
Original product of Genprex, Inc.

For the biotech startup Genprex, Inc. (GNPX), which is developing a scalable cancer gene therapy platform, long-term financing is critical for completing costly research. Analyzing the company's long-term debt level, which currently stands at 0.00, an investor assesses the total volume of liabilities with maturities exceeding one year, which determines the business's degree of financial autonomy and its ability to invest in innovative drugs.

Analysis of competing companies

Company Long-Term Indebtedness beigene.com ONC|HALO: Company Long-Term Debts|RVMD - Company Long-Term Liabilities|Company Long-Term Debts AAPG|CGON (CG Oncology Therapeutics) - Long-Term Debt|URGN - Company Long-Term Debt|Company Long-Term Loans and Borrowings bicara.com (BCAX)|Personalis (PSNL) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Erasca Inc (ERAS)|Delcath - Company Long-Term Debts|YMAB - Company Long-Term Liabilities|Aura Biosciences, Inc. - Company Long-Term Liabilities|CADL: Company Long-Term Debts|Company Long-Term Debt Accuray ARAY|SELLAS Life Sciences Group (SLS) - Company Long-Term Loans and Borrowings|Company Long-Term Debts ACTU (Actuate Therapeutics, Inc)|Long-Term Debt Citius Oncology Inc|HURA: Company Long-Term Debts|Long-Term Indebtedness protaratx.com (TARA)|FATE: Company Long-Term Debts|Aadi Bioscience, Inc. - Long-Term Debt|TScan (TCRX) - Company Long-Term Debt|CSBR: Company Long-Term Indebtedness|Company Long-Term Debt xbiotech.com (XBIT)|CVM (CEL-SCI) - Long-Term Liabilities|OSTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings Radiopharm Theranostics Ltd|Artiva Biotherapeutics, Inc. - Company Long-Term Debts|Long-Term Debt adlainortye.com ANL|VERU - Company Long-Term Liabilities|TPST - Company Long-Term Indebtedness|Company Long-Term Liabilities Xilio (XLO)|RENB - Company Long-Term Loans and Borrowings|muraloncology.com - Company Long-Term Debts|KAPA (Kairos Pharma) - Long-Term Debt Volume|Company Long-Term Debt OnKure Therapeutics, Inc. (OKUR)|Company Long-Term Indebtedness CytoMed|Company Long-Term Debts CRIS (Curis, Inc.)|Company Long-Term Liabilities apollomicsinc.com APLM|Company Long-Term Liabilities THAR|Long-Term Debt Volume Advanced Biomed Inc. ADVB|Company Long-Term Debts CLDI|SBFM: Long-Term Indebtedness|Company Long-Term Debt xeneticbio.com|SLRX (Salarius Pharmaceuticals Inc) - Company Long-Term Indebtedness|Company Long-Term Debt Purple Biotech Corp PPBT|Long-Term Liabilities AON (AONC)|Company Long-Term Liabilities BeiGene, Ltd. BGNE|Company Long-Term Indebtedness checkpointtx.com (CKPT)|Elevation Oncology, Inc. - Company Long-Term Debts|Company Long-Term Liabilities iCAD Inc. ICAD|Ikena - Company Long-Term Debts|NTBL: Company Long-Term Debts|Company Long-Term Debt viracta.com|morphosys.com (MOR) - Company Long-Term Indebtedness|Company Long-Term Debts NAYA|Company Long-Term Liabilities Ascentage Pharma Group International